LEP and cancer: Consistent with this concept, recently two independent studies reported that an increased local leptin/LepR response driven by expanded hypodermal adipocytes leads to a chronic wound; and augmented leptin level in malignant tumor microenvironment facilitates benign-to-malignant transition through acting on LepR-expressing cancer stem cells53,54.